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ABSTRACT 
Mammalian metallothioneins (MT) are induced by various immunomodulatory molecules and 
are involved in a spectrum of immune processes such as essential metal homeostasis, 
detoxification of certain heavy metals, inflammation, and immune cell trafficking [1-3]. A 
bacterial metallothionein, SmtA, shares some sequence homology with mammalian MT as well 
as its metal-binding capabilities [4]. In addition to its ability to sequester heavy metals, 
eukaryotic MT has also been shown to scavenge free radicals such as reactive oxygen and 
nitrogen species (ROS, RNS), interfering with their toxic effects on cells and potentially 
influencing their regulatory roles in cell proliferation and differentiation [5, 6]. Over the course 
of a bacterial infection, innate immune cells undergo a respiratory burst where they release ROS 
as bactericides, during which mammalian MT protects the host cell against self-inflicted 
oxidative damage. We hypothesize that SmtA defends bacteria against inflammatory ROS in a 
manner similar to mammalian MT. We have shown (using transfected Escherichia coli) that 
SmtA provides protection to E. coli from some forms of oxidative stress and that SmtA can also 
protect E. coli when co-cultured with RAW264.7 macrophage cells. Further exploration will be 
necessary to determine whether SmtA provides protection against mammalian immune defense 
mechanisms in vivo. These initial in vitro results have provided motivation to continue these 
studies. 
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INTRODUCTION 
Immunomodulatory properties of mammalian MT 
Eukaryotic metallothioneins (MT) are highly conserved, small molecular weight proteins 
(~7kDa) rich in cysteine residues (Ca. 33 mol %). The cysteines present in MT provide the 
protein with many of its functional characteristics including the ability to bind heavy metals, 
scavenge reactive oxygen and nitrogen species (ROS, RNS), elicit chemotaxis, and influence 
immune cell trafficking. In mammalian cells, MT acts as a stress response protein and is induced 
by various immunomodulatory molecules such as divalent heavy metals, endotoxin, interferon, 
ROS, and RNS [7-12]. Its role as a stress response protein as well as its known interactions with 
various immune molecules indicate that MT is an important mediator of an effective immune 
response.  
In total, four isotypes of mammalian metallothioneins have been identified, all of which 
are encoded in a gene cluster located on chromosome 8 in mice and chromosome 16 in humans 
[13]. MT-I and MT-II are widely expressed in vivo throughout development and throughout all 
cell types as well as in most cell lines. The remaining two isoforms, MT-III and MT-IV, have 
more restricted expression and are found predominantly in the brain (MT-III) or squamous 
epithelial cells (MT-IV) [14, 15].  
MT is a major contributor in regulating essential metal homeostasis. Mammalian 
metallothioneins have been isolated naturally containing essential metals such as zinc and 
copper. The numerous thiol (SH) groups allow MT to bind 7-8 zinc and 9-11 copper ions [16]. 
Zinc is especially important to an effective immune response. In humans, zinc deficiency has 
been associated with thymic atrophy, decreased lymphoproliferation, decreased ratios of 
CD4+/CD8+ cells, decreased NK cell activity, and decreased monocyte cytotoxicity, all of which 
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result in diminished immune capacity [17].  Many studies have shown that MT regulates the 
amount of free zinc present in cells as well as the amount of zinc available for molecules 
important to immune function such as zinc-finger transcription factors, structural 
metalloproteins, and zinc-dependent apoenzyme [17, 18]. In this way, MT contributes to the 
effectiveness of the immune response by storing and providing elemental zinc to immune 
molecules requiring zinc for proper function.   
MT may also contribute to the host’s immune response during microbial infections by 
sequestering essential metals from infectious organisms. Bacteria incorporate zinc into a 
predicted 4-6% of their proteome. Zinc is required for bacterial gene expression, cellular 
metabolism, and as a cofactor of numerous virulence factors [19]. Therefore, it is no surprise that 
Zinc chelation and sequestration is one way host organisms have been shown to restrict 
infectious bacterial growth. For example, it has been shown that during infection zinc chelation 
by calprotectin (a host protein produced by neutrophils) inhibits the growth and survival of 
Staphylococcus aureus [2]. Aside from calprotectin, other studies have shown ZIP/Znt 
transporters are important in host zinc sequestration as well [19]. These results suggest 
metallothionein may also inhibit bacterial growth and aid the host’s immune response during an 
infection by sequestering essential metals necessary for bacterial growth.    
In addition to essential metals like zinc and copper, mammalian metallothioneins have 
been isolated naturally containing toxic heavy metals such as cadmium and mercury. MT also 
exhibits affinity for other reactive metal ions in vitro including Pb, Ni, Co, Fe, Ag, and Au [16, 
20]. MT’s ability to sequester cadmium and other toxic heavy metals has been shown to enhance 
cell survival by preventing toxic divalent metal cations from interacting with and damaging other 
parts of the cells. For instance, it has been shown that during cadmium exposure, MT binds 
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cadmium with high affinity, sequestering the toxic cationic cadmium in a CdMT complex that is 
relatively inert and prevents immediate cadmium cytotoxicity [16, 21].  
Aside from its ability to bind metals, mammalian MT also participates in regulating the 
redox potential of cells. During times of oxidative stress, MT is able to scavenge free radicals 
such as ROS and RNS, interfering with their cytotoxicity [5, 6, 22]. In particular, MT has been 
shown to scavenge hydrogen peroxide, hydroxyl radicals, and nitric oxide [23-25]. In 
mammalian cells, free radicals are produced during both normal cellular activities and in the 
context of many pathological processes (Fig. 1). For instance, ROS are formed as byproducts 
during metabolism, from interaction with cationic Cd or other toxic heavy metals, and during 
inflammation.  
During the course of a bacterial infection, innate immune cells undergo a respiratory 
burst in which they release bactericidal ROS into the extracellular space and phagocytic vesicles. 
Oxidant species known to be released during the respiratory bursts of macrophages and 
neutrophils include nitric oxide (NO), superoxide anions (O2-), hydrogen peroxide (H2O2), 
hydroxyl radicals (.OH), and hypochlorite (OCl-) [26].  Although ROS are released as 
bactericides, they can also cause unwanted damage to the host cell by leaking across host cell 
membranes. Mammalian MT, however, is able to scavenge and neutralize ROS in the cell, 
limiting oxidative damage to the host.   
Three mechanisms operate in producing the respiratory burst. The first mechanism 
involves the NADPH oxidase located at the plasma membrane. The NADPH oxidase forms 
superoxide anions in a reaction with NADPH, molecular oxygen, and hydrogen ions. Superoxide 
radicals then form hydrogen peroxide in a secondary reaction, which can occur spontaneously or 
catalyzed by superoxide dismutase (SOD) (Fig. 2A).  In a second mechanism, the products of the 
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NADPH oxidase system (e.g. superoxide anions and hydrogen peroxide) form the potent 
hydroxyl radical via the Haber-Weiss reaction (Fig. 2B). Finally, a third mechanism mediated by 
myeloperoxidase (MPO) results in the formation of hypochlorous acid (HOCl), which partially 
dissociates into hypochlorite radicals (Fig. 2C). The MPO enzyme is only present in granules of 
neutrophils and monocytes but disappears from differentiated macrophages. Although 
macrophages cannot synthesize MPO, they have been shown to take up neutrophil-generated 
MPO by endocytosis and phagocytosis. Together, these mechanisms account for the microbicidal 
release of ROS [27]. 
 Mammalian MT expression is driven by a variety of cellular factors including the 
presence of metals ions and oxidative stress [28]. In the presence of zinc, the MRE-binding 
transcription factor 1 (MTF-1) binds to metal response elements (MREs) proximal to the MT 
promoter to initiate transcription. Upregulation of MT by other metals seems to be indirectly 
regulated. In vitro, the MT promoter (including relevant MREs and soluble MTF) is induced 
only in the presence of zinc; other metals do not initiate transcription. Upon introduction of 
ZnMT complexes, however, other metals are capable of activating transcription. This data 
supports the current hypothesis that one way metals other than zinc upregulate MT expression is 
by displacing zinc from the ZnMT complex, thereby releasing free zinc for MTF binding [29].  
Similarly, an antioxidant response element (ARE) located upstream of the MT gene also 
participates in activating MT transcription in response to ROS [28]. In general, AREs positively 
regulate genes involved in the oxidative stress response such as superoxide dismutase, 
glutathione peroxidase, and glutathione-S-transferase [30]. Gene activation at the ARE occurs 
when the transcription factors, Nrf1 or Nrf2, are translocated to the nucleus in response to 
oxidative stress, subsequently binding to the ARE [31]. Mice deficient in Nrf1 or Nrf2 exhibited 
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severely decreased MT-1 gene expression (10-20% of wild-type) and MT-1 gene expression was 
undetectable in mice deficient in both Nrf1 and Nrf2, suggesting substantial involvement of Nrf1 
and Nrf2 signaling at the MT promoter [32]. Furthermore, during oxidative stress, upregulation 
of MT is positively regulated by the release of MT-bound zinc, which acts at the MRE to 
additionally increase MT gene transcription. Studies suggest that other signal transduction 
cascades are also involved in MT expression [33].  
 
Bacterial metallothionein, SmtA, may share MT’s immunomodulatory properties 
These observations regarding mammalian MT suggest a bacterial metallothionein, SmtA, may 
similarly influence the mammalian immune response. SmtA has been found in Pseudomonas 
aeruginosa and Synechococcus species where its role as a metal-binding protein is already 
established [34-36]. A sequence alignment between SmtA and mammalian MT shows possible 
alignments between various cysteine residues, which are known to be important in metal 
binding, as well as other sequence similarities (Fig. 3). In addition to cysteine motifs, it is 
thought that several histidine residues contribute to SmtA’s ability to bind metals as well. A total 
of 8-9 cysteine and 3 histidine residues [37] allow SmtA to bind, on average, 3-4 zinc molecules 
[4, 38]. Further functional comparison of eukaryotic and prokaryotic metallothioneins is shown 
in Table 1.   
SmtA is capable of binding heavy metals similar to the set known to bind mammalian 
MT (e.g. Zn, Hg, Cd, Cu, Co, Cr, and Ni) [39]. SmtA has been implicated in bacterial protection 
against either zinc or cadmium toxicity [34]. For example, Synechococcus SmtA mutants 
demonstrate a five-fold reduction in zinc toleration, which can be restored by exogenous 
recombinant SmtA [40]. SmtA mutants also demonstrate decreased accumulation of exogenous 
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zinc, suggesting SmtA functions in zinc sequestration and storage. This may indicate a selective 
advantage of SmtA-expressing cells in nutrient-deficient environments. Finally, SmtA-
overexpressing cells do not demonstrate a detrimental phenotype, implying that SmtA in excess 
does not scavenge Zn or other essential ions from requiring proteins [41].  
Like mammalian MT, SmtA is inducible in the presence of heavy metals. In contrast, 
however, SmtA expression is under a form of negative regulation. Its expression is controlled by 
the metalloregulatory protein SmtB, which normally binds the SmtA operator-promoter region in 
the absence of zinc, preventing transcription of the SmtA gene (Fig. 4). At low concentrations, 
active SmtB (apo) binds the operator-promoter site as a dimer. At higher concentrations, up to 
four SmtB molecules can bind the operator-promoter at one time, forming a tetrameric complex 
that physically hinders RNAP binding (Fig. 5) [42]. Similar to the regulation of mammalian MT, 
only zinc is capable of binding SmtB, yet other metals are known to activate SmtA expression. A 
similar mechanism to that proposed for eukaryotic MT expression by metals other than zinc has 
been suggested in the prokaryotic system [35]. Other factors contributing to SmtA expression 
have not yet been explored. It is likely, however, considering the large spectrum of molecules 
influencing mammalian MT expression that SmtA expression is also subject to additional modes 
of transcriptional activation or inhibition.  
SmtA is known to share mammalian MT’s metal-binding capabilities, and its induction 
through the metallo-regulated SmtB pathway is well understood. There is a lack of research, 
however, exploring the possibility of other roles for SmtA. Mammalian MT’s ability to scavenge 
ROS is important to its interaction with the immune response, and if this property of MT were 
shared with its bacterial homolog, we hypothesize that SmtA could represent a virulence factor 
in specific bacterial pathogens. 
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Mammalian MT’s ability to bind and neutralize ROS protects host immune cells from 
self-inflicted oxidative damage. Because SmtA shares cysteine motifs with MT, it may be able to 
scavenge ROS in a similar manner and protect bacteria from ROS during infection. Protection 
from oxidative stress could aid in bacterial survival and increase the virulence of an SmtA-
expressing bacterium, such as Pseudomonas aeruginosa. P. aeruginosa infections commonly 
occur in the airways of immunocompromised individuals and account for  10.1% of hospital-
acquired infections [43]. If SmtA indeed influences bacterial resistance to immune attack, it may 
represent a valuable target for therapeutic intervention. 
Various microbial strategies exist to evade ROS-dependent killing. For example, 
Staphylococcos aureus exploits endogenous catalase levels in order to resist bactericidal 
oxidative damage (catalase neutralizes hydrogen peroxide by catalyzing its decomposition to 
water and molecular oxygen). Mandell et. al. (1979) demonstrated that S. aureus strains with 
high catalase levels were significantly more resistant to neutrophil-mediated killing and 
significantly more virulent in their mouse model when compared to S. aureus with low catalase 
levels [27]. Similar results were shown using Listeria monocytogenes [27]. We suspect, like 
catalase, high SmtA levels may increase bacterial resistance to ROS-mediated killing by 
neutralizing ROS such as hydrogen peroxide. 
Further support that a bacterial metallothionein like SmtA may function in pathogenesis 
comes from the pathogen-host relationship between Magnaporthe grisea, a type of fungus, and 
Oryza sativa (rice). M. grisea infects rice plants by forming specialized structures, appressoria, 
that rupture the plant cuticle and allow entry of the infection. During infection, a Type I rice 
metallothionein expressed constitutively in healthy plants shows significant upregulation [44]. A 
separate study examining fungal pathogenicity implicated a M. grisea metallothionein, MMT1, 
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in functional appressoria formation [45]. M. grisea MMT1 mutants were unable to undergo 
appressoria-mediated penetration and failed to cause disease in rice plants. Reintroducing a 
functional MMT1 gene restored penetration and subsequent pathogenicity. This suggests that 
metallothioneins participate in host defense mechanisms and as pathogen virulence factors.  
One source of oxidative attack against which SmtA might offer protection is the 
respiratory burst of innate immune cells. In addition to the concentrated release of ROS by host 
macrophage and neutrophils, airway pathogens such as P. aeruginosa are also subject to 
atmospheric concentrations of molecular oxygen, creating a relatively high oxidative 
environment. A further context in which the ability to bind and neutralize ROS would be 
beneficial to Pseudomonas is during biofilm formation. Studies have shown that biofilms form 
more readily in anaerobic microenvironments and that ROS can be used to disperse already 
formed biofilms in Pseudomonas aeruginosa culture [46]. Biofilms often exacerbate mammalian 
infections by increasing bacterial resistance to antibiotics. Antibiotics promoting the formation of 
ROS, however, have been shown effective in inhibiting the development of E. coli biofilms [47]. 
Thus, if able to scavenge ROS as we hypothesize, SmtA may play a role in promoting biofilm 
formation. 
 Given the sequence similarities (Fig. 1) and shared properties between eukaryotic and 
prokaryotic metallothioneins (Table 1), it is likely that SmtA shares properties with mammalian 
MT that have not yet been explored. The role of SmtA in metal sequestration has been well 
documented; however, its ability to scavenge and neutralize ROS is unknown. Our research is 
designed to establish whether or not SmtA has the capacity to bind and neutralize ROS and to 
explore whether the presence of SmtA is a factor in bacterial survival during infection. Our 
hypothesis is that SmtA binds and neutralizes ROS, protecting bacteria from oxidative stress 
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elicited during the inflammatory response and contributing to bacterial survival during the 
respiratory burst of innate immune cells.  
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MATERIALS AND METHODS 
Materials.  
Hydrogen peroxide (30%) was purchased from Fisher Scientific Inc. (Pittsburgh, PA). Tert-butyl 
hydroperoxide (70%), luminol, ampicillin, glutathione (GSH), and catalase were purchased from 
Sigma-Aldrich (St. Louis, MO). Sodium hypochlorite (2.5% w/w) was purchased from Ricca 
Chemical Company (Arlington, TX). Clear and white 96-well culture-treated plates were 
purchased from Nalge Nunc International (Rochester, NY).  Black 96-well Microflour-2 plates 
were purchased from ThermoLabsystems (Franklin, MA). Hank’s balanced salt solution (HBSS) 
was purchased from Thermo Scientific Hyclone (Logan, UT). Horseradish peroxidase (HRP) 
was purchased from Thermo Fisher Scientific (Waltham, MA). Isopropyl-β-D-thiogalactoside 
(IPTG) was purchased from Gold Biotechnology (St. Louis, MO). N-[4-(7-diethylamino-4-
methyl-3-coumarinyl)phenyl]maleimide (CPM) was purchased from Invitrogen (Carlsbad, CA). 
 
Cells.  
E. coli MC1061 cells (ATCC 53338) were cultured in YTA media. RAW267.4 cells (ATCC 
TIB-71) are a mouse macrophage cell line and were cultured in RPMI media supplemented with 
1% penicillin-streptamycin, 25mM Hepes, 4mM L-glutathione, and 10% fetal bovine serum 
(FBS).  
 
Plasmid construction and transformation of MC1061 E. coli.  
The Pseudomonas aeruginosa SmtA gene (YP_791105) was cloned into the pGEX-6P-1 
expression vector (Amersham) between the EcoRI and XhoI sites (pGEX-SMTA) (D. Laukens, 
U. Ghent) (Fig. 6). MC1061 E. coli + pGEX-SMTA were generously provided by D. Laukens 
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(sequence verified). MC1061 E. coli was transfected with the pGEX-6P-1 empty vector using the 
calcium chloride procedure and transfected cells were selected by plating on YTA plates 
containing 100ug/ml ampicillin. Successful transformation was verified by isolating the plasmid 
DNA from a 24-hour culture of MC1061 + pGEX-6P-1 according to Maniatis et. al. 1982. The 
minipreparation was analyzed by gel electrophoresis on a 1% agarose gel containing 0.5ug/ml 
ethidium bromide (Figure 6). MC1061 + pGEX-SMTA and MC1061 provided by D. Laukens 
were analyzed as well. Under IPTG induction, the transfected E. coli express either a GST-
tagged SmtA protein or GST (glutathione S-transferase) alone.  
 
In vitro exogenous oxidant exposure.   
The MC1061+pGEX-SMTA and MC1061+pGEX-6P-1 E. coli were subcultured from overnight 
cultures to log phase (0.2 OD600) in YTA media containing ampicillin (100ug/ml) and IPTG 
(100uM). The cultures were then exposed to the various concentrations of hydrogen peroxide 
(H2O2), tert-butyl hydroperoxide (tBOOH), or sodium hypochlorite (NaOCl) ranging from 3mM 
to 15mM, aliquoted into 96-well plates, and maintained at 37oC with constant shaking. Survival 
was monitored at OD600 and represented graphically as percent absorbance of untreated control. 
Samples were taken at 60 minutes post treatment and plated on YTA plates supplemented with 
ampicillin. Plates were then incubated inverted overnight at 37oC to determine CFU/ml.  
 
Infection of RAW267.4 macrophage. 
E. coli MC1061 expressing either plasmid construct were grown overnight and subcultured in 
rich media to log phase (0.2 OD600)  with IPTG (100uM) and ampicillin (100ug/ml). The 
RAW264.7 cells were grown 72 hours, plated in 6 well plates, and allowed to adhere 2.5 hours in 
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5% CO2.The RAW264.7 cells were then infected with E. coli at an MOI of 5:1 and incubated in 
10% CO2 and 7% O2 at 37oC. The supernatant was removed after 30 minutes and after 24 hours 
and plated on YTA plates supplemented with ampicillin and IPTG to determine CFU/ml. 
 
Long term MC1061 E. coli culture 
MC1061 E. coli cultures (Parent MC1061 E. coli, MC1061 + pGEX-SmtA, and MC1061 + 
pGEX-6p-1) were subcultured from overnight cultures in YTA media and allowed to grow at 37o 
under constant shaking. MC1061 + pGEX-SmtA and MC1061 + pGEX-6p-1 cultures were 
grown in media containing ampicillin (100ug/ml) and IPTG (100uM). The MC1061 parent strain 
was grown in media supplemented with IPTG (100uM). At the time points indicated, a sample of 
each culture was plated on YTA plates to determine CFU/ml. MC1061 cells were plated on YTA 
plates supplemented with IPTG and MC1061 + pGEX-SmtA or + pGEX-6p-1 cells were plated 
on YTA plates supplemented with ampicillin and IPTG. 
 
Luminol assay. 
GSH (0.32-10mM) and catalase (20U/well) were prepared in HBSS. Samples were exposed to 
1mM H2O2 in HBSS for 30 minutes at room temperature. The redox potential of each solution 
was then determined using a working solution of 0.1mM luminol and 50ug of HRP. Samples 
were aliquoted into a white 96-well plate and the luminescence immediately read at 420nm. The 
value of the blank (HBSS and luminol-HRP working solution) was subtracted from each well.  
 
 
 
Davis 
 16 
CPM assay. 
Stock solutions of GSH and N-acetyl-L-cysteine (10mM) were freshly prepared in PBS and then 
diluted as needed. A stock and working solution of CPM was prepared as previously described 
by Ayers et. al. 1986 [48]. Sample solutions of GSH and N-acetyl-L-cysteine were prepared to 
yield 0.1-0.4nmol/well. The CPM working solution and sample solutions were added to a black 
Microflour-2 96-well plate in triplicate in a 1:1 ratio (100ul of CPM working solution and 100ul 
of sample solution). The plate was incubated in the dark at room temperature for 1 hour and then 
read immediately with a excitation wavelength of 387nm and an emission wavelength of 465nm. 
The value of the blank (100ul of CPM working solution and 100ul of PBS) was subtracted from 
each well.  
 
Statistics. 
The results for in vitro exogenous oxidant exposure and infection of RAW 267.4 macrophages 
were analyzed using Student’s t-test. Where experiments were done in triplicate standard 
deviation values are included.  
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RESULTS 
In vitro exposure to exogenous oxidants 
MC1061 E. coli were transfected with a pGEX-6p-1 plasmid containing the P. aeruginosa SmtA 
gene under IPTG induction (pGEX-SMTA).  A control pGEX-6P-1 plasmid (empty vector) was 
transfected into the same strain of E. coli for use as a negative control. In the presence of IPTG, 
the pGEX-SMTA plasmid expresses a GST-tagged SmtA protein while the pGEX-6P-1 plasmid 
expresses only the GST protein. Successful transformation was confirmed by isolating bacterial 
DNA from 24-hour cultures and analyzing the minipreparation by gel electrophoresis on a 1% 
agarose gel containing 0.5ug/ml ethidium bromide (Fig. 7). The pGEX-SMTA and pGEX-6P-1 
plasmids ran at the expected molecular weights, with the pGEX-SMTA band shifted slightly 
upward due to the additional 242 base pairs encoding the SmtA gene.  
 Bacteria expressing either the pGEX-SMTA or pGEX-6P-1 construct were sub-cultured 
from IPTG-induced overnight cultures in a rich media to early log phase (0.2 OD600) and treated 
with multiple concentrations of hydrogen peroxide (H2O2), tert-butyl hydroperoxide (tBOOH), or 
sodium hypochlorite (NaOCl) as a source of oxidative stress. Both H2O2 and tBOOH have been 
used previously in the literature as models of cellular oxidative stress [49]. We included NaOCl 
as well since hypochlorite radicals are present in the respiratory bursts of innate immune cells 
[26]. Cultures were aliquoted in triplicate into 96-well plates and bacteria were monitored at 
OD600 every 30 minutes for 3 hours. Survival of the bacteria was expressed as percent of 
untreated controls.  
 When treated with H2O2 at a range of concentrations, both SmtA-containing and SmtA-
deficient strains showed a dose-dependent response. As the concentration of H2O2 increased, the 
bacteria were less able to survive and grow. At each concentration of H2O2, the SmtA-expressing 
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E. coli were better able to survive the treatment than the control strain lacking SmtA (Fig. 8). 
Because the only difference between the two strains is the inducible SmtA gene present in the 
pGEX-6p-1 plasmid of the SmtA-expressing bacteria, the resistance towards H2O2 was 
concluded to be due to the presence of SmtA.  
In addition to using H2O2 as a source of oxidative stress, parallel experiments were 
completed using two other oxidants, tBOOH and NaOCl, in order to further test the anti-oxidant 
capacity of SmtA. Testing multiple oxidants provides a more complete understanding of the 
extent to which SmtA offers protection to the bacteria. Unlike the effect observed after H2O2 
exposure, we did not find a significant difference between the responses of SmtA-expressing and 
SmtA-deficient bacteria when treated with either tBOOH or NaOCl (Fig. 8). This data suggests 
that the anti-oxidant protective effect of SmtA is not universal.  
The pattern of bacterial survival when treated with tBOOH was strikingly different than 
the pattern of survival observed when treated with H2O2 or NaOCl. When treated with H2O2 or 
NaOCl, the bacteria exhibited a dose-dependent response to the oxidant. In contrast, when the 
bacteria were treated with tBOOH we did not observe a dose-dependent response; rather, the 
bacteria exhibited the same degree of survival at every concentration of tBOOH tested (final 
concentrations of 3-15mM) (Fig. 8). 
To ensure that absorbance was representative of bacterial survival, we repeated the 
exposure to 10mM H2O2 and measured viable bacteria by plating and counting colonies 
(CFU/ml). The bacteria expressing each plasmid construct were cultured and then treated with 
10mM H2O2 according to identical protocols. At 60 minutes post treatment, a sample was taken 
from both cultures (MC1061 + pGEX-SmtA and MC1061 + pGEX-6p-1) and plated to 
determine CFU/ml. We found that at 60 minutes post treatment with 10mM H2O2, the SmtA-
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expressing bacteria were better able to survive and grow than the SmtA-deficient bacteria, 
supporting the results that relied on OD600  as an indicator of bacterial survival (Fig. 9). 
 
In vitro infection of RAW 267.4 macrophages 
We were able to show that SmtA protects E. coli from exogenous H2O2. We also wanted to 
determine whether SmtA enhances the survival of E. coli when challenged with ROS released 
during the respiratory burst of macrophages. To do so, we measured the survival of E. coli 
MC1061 containing each plasmid construct after infection of RAW 267.4 murine macrophages. 
Macrophages are one of the first types of immune cells present at an infection site, and upon 
exposure to endotoxin, macrophages are known to undergo a respiratory burst during which ROS 
are released as bactericides [26]. 
 Bacteria expressing each plasmid construct were grown overnight and subcultured to 
early log phase (0.2 OD600) in YTA media. RAW 267.4 cells were grown to confluency in 6-well 
plates, and infected with the E. coli at a 5:1 multiplicity of infection (MOI). After 30 minutes of 
infection, the supernatant was removed and plated on YTA plates to enumerate surviving 
bacteria. Surviving cell numbers were also determined after 24 hours of infection according to 
the same protocol. By taking our sample from the supernatant we assayed the survival and 
growth of extracellular bacteria exposed to the respiratory burst. We did not, however, determine 
the survival of intracellular bacteria that had been phagocytosed by the macrophage. The 
numbers of viable SmtA-expressing bacteria were larger than SmtA-deficient bacteria at 30 
minutes and 24 hours post infection (Fig. 10). This data suggests that SmtA confers a survival 
advantage to E. coli in the oxidative environment produced during the respiratory burst of 
macrophages.  
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Long-term culture 
In the previous experiments, we were most interested in how the presence of SmtA affects 
bacteria exposed to high oxidative stress environments (e.g. concentrated exogenous oxidant, 
respiratory burst of macrophage). In normal culture conditions, however, bacteria are constantly 
exposed to oxidative stress by way of atmospheric oxygen. Although less of an immediate 
danger to cells than the concentrated release of ROS during the innate immune response, 
atmospheric oxygen may be a factor in bacterial survival during long-term culture conditions. If 
so, the presence of SmtA, either exogenous or intracellular, may ameliorate gradual oxidative 
damage to cells, thereby increasing the survival of bacteria in long-term culture.    
 Wildtype MC1061, MC1061 + pGEX-SmtA, and MC1061 + pGEX-6p-1 E. coli were 
subcultured from overnight cultures in rich media and allowed to grow at 37o under constant 
shaking. Every 24 hours for 6 days, a sample of each culture was plated on YTA plates to 
determine CFU/ml. Preliminary results indicate a slight advantage from 72 hours on in SmtA-
expressing bacteria when compared to SmtA-deficient bacteria (Fig. 11). Initially, however, 
bacteria expressing the pGEX-6p-1 plasmid were greater in number than wildtype MC1061 or 
SmtA-expressing bacteria. The advantage over wildtype MC1061 may be due to some factor 
inherent in the pGEX-6p-1 vector. The initial advantage over SmtA-expressing cells could be 
explained by protein burden: SmtA-expressing bacteria grow more slowly than the SmtA-
deficient bacteria carrying the pGEX-6p-1 plasmid because additional protein (e.g. SmtA) must 
be transcribed and translated, which requires both time and energy. These preliminary results are 
interesting but must be repeated with replicate cultures. 
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DISCUSSION 
SmtA binds and neutralizes ROS 
SmtA-expressing MC1061 E. coli demonstrated increased survival and growth compared to 
MC1061 E. coli deficient in SmtA when exposed to exogenous H2O2. When treated with other 
ROS (e.g. tBOOH and NaOCl), we did not observe increased survival in SmtA-expressing 
bacteria. This suggests that SmtA plays a role in defending bacteria against ROS, but this 
protective effect is not universal to all forms of oxidative stress. This is not surprising, as it has 
been shown previously that mammalian MT scavenges certain oxidants, such as hydroxyl 
radicals, more efficiently than others. For instance, MT’s ability to scavenge hydroxyl radicals is 
three hundred times that of GSH, the most abundant antioxidant present in cells. GSH, however, 
is better able to scavenge superoxide radicals [24]. Additional oxidants to be tested include 
superoxide anions and nitric oxide in order to further profile the scavenging potential of SmtA.  
We were also able to show that SmtA-expressing bacteria are better able to survive and 
grow during RAW 267.4 macrophage infection. This evidence establishes further support for 
SmtA as a bacterial antioxidant. Macrophages are one of the first types of immune cells to 
respond to an infection. In addition to their phagocytic activity, macrophages undergo a 
respiratory burst during which various ROS are released into the extracellular environment as 
bactericides. By determining the survival and growth only of bacteria recovered from the 
supernatant, we limited our analysis to extracellular bacteria exposed to the respiratory burst. At 
this time, we do not know whether SmtA affects the effectiveness of phagocytosis or the survival 
of bacterial when phagocytosed. Because the phagosome also contains a high concentration of 
ROS, the presence of SmtA may increase the survival of phagocytosed bacteria as well, 
providing a further advantage to SmtA-expressing bacterium during infection.  
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From these initial experiments, it appears that SmtA shares eukaryotic MT’s ROS 
scavenging capabilities in addition to its already established metal-binding function. 
Demonstrating the antioxidant capacity of soluble SmtA would provide further evidence that the 
protective effect of SmtA is due to its ability to bind and neutralize ROS. We have begun to 
purify the GST-SmtA fusion protein from the MC1061 + pGEX-SMTA E. coli using GSH resin. 
Once purified, the GST tag can be removed from the SmtA protein using a GST precision 
protease.  
Various biochemical properties could be explored with an available stock of soluble 
recombinant SmtA. For instance, if our hypothesis that SmtA binds and neutralizes ROS is valid, 
incubating different concentrations of soluble SmtA with H2O2 should elicit a dose-dependent 
decrease in oxidant activity. ROS can be detected in solution using an enhanced luminol-based 
chemiluminescence assay [50]. Oxidation of luminol upon exposure to ROS such as H2O2 results 
in chemiluminescence that is proportional to the amount of ROS in solution. The enhanced assay 
includes horseradish peroxidase (HRP) to increase sensitivity. To show this approach would be 
appropriate for use with SmtA, we optimized the assay using GSH.  Different concentrations of 
GSH were incubated with 1mM H2O2 in HBSS for 30 minutes. A working solution of luminol-
HRP was added and samples were aliquoted into a 96-well white plate.  Luminescence was 
immediately read at 420nm. As the concentration of GSH increased, less oxidation was detected 
(Fig. 12). Catalase, which catalyzes the decomposition of H2O2, was included in the experiment 
as a positive control. GSH, in the absence of H2O2, did not elicit chemiluminescence. These 
results indicate that the enhanced luminol-based chemiluminescence assay should be appropriate 
in analyzing the scavenging activity of SmtA.   
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In addition to showing that soluble SmtA is capable of neutralizing ROS in the absence 
of other cell material using luminol chemiluminescence, we would also like to quantify and 
compare the number of reactive thiols found in SmtA using the thiol-reactive probe, N-[4-(7-
diethylamino-4-methyl-3-coumarinyl)phenyl]maleimide (CPM) [48]. Similar to the enhanced 
luminol-based chemiluminescence assay, we first optimized the CPM assay using GSH, which 
contains one thiol group per molecule of GSH. In addition to GSH, we included N-acetyl-L-
cysteine, which also contains one thiol per molecule. Our results corroborated those found 
previously, demonstrating a linear relationship between CPM reactivity and moles of GSH (Fig. 
13). As expected, CPM reactivity with N-acetyl-L-cysteine was similar to that of GSH with no 
statistical significance between GSH and N-acetyl-L-cysteine samples at each concentration 
tested. Upon obtaining purified soluble SmtA, the CPM assay may be repeated to determine the 
number of reactive thoils per molecule of SmtA using a GSH standard curve. 
 
 
SmtA gene regulation 
We show here that SmtA protects transgenic E. coli from oxidative attack. Because our data 
suggests SmtA is beneficial to the organism during periods of oxidative stress, we hypothesize 
there may be a mechanism by which SmtA expression is increased by ROS signaling. The 
mammalian MT locus contains an ARE necessary for ROS-activated gene transcription. In 
addition, ZnMT complexes are known to release bound zinc in order to bind ROS, increasing 
cellular zinc levels available to act at the metal response element (MRE). Similar mechanisms 
may be at work in the prokaryotic system. If gene expression were to increase in response to 
oxidative stress, SmtA’s role in protecting against ROS would be positively amplified. 
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SmtA and chemotaxis 
Our research thus far has been focused on the interaction between SmtA and ROS released 
during the inflammatory response because the literature shows this is an important function of 
mammalian MT and an area of research that has not yet been addressed concerning bacterial 
metallothioneins. An additional immunomodulatory function of MT that SmtA may share is the 
ability to induce chemotaxis and influence immune cell trafficking.  
 MT has been found extracellularly in numerous circumstances, including in culture 
media, serum, urine, bronchoalveloar fluid, liver sinusoids, inflammatory lesions, and in other 
secretions and excretions [51-58]. Classical protein secretion occurs through ER targeting of a 
nascent polypeptide, which requires a N-terminal signal sequence. MT does not contain a signal 
sequence necessary for this type of classical secretion. With a growing repertoire of selectively 
secreted molecules that lack a signal sequence, several non-classical mechanisms have been 
suggested in the literature by which these molecules are released extracellularly. For example, 
both IL-1α and IL-1β are associated with the cellular stress response and are thought to be 
secreted non-classically through interaction with specialized endolysosomes [59]. As yet, there is 
no conclusive evidence that MT is secreted selectively rather than as a byproduct of membrane 
compromise or necrotic cell death. MT does, however, share similarities with other proteins 
known to be secreted by non-classical pathways.  
It is likely that MT has the same functional properties in the extracellular environment as 
it does inside the cell, namely its ability to bind heavy metals and free radicals due to its thiol-
rich nature. More interestingly, however, there is evidence suggesting extracellular MT may 
have additional characteristics outside of cells that allow it to function as a chemotactic factor 
and influence immune cell trafficking. The primary amino acid sequence of MT contains 
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cysteines arranged in C, C-C, C-X-C, and C-X3-C motifs [13]. These motifs are characteristic of 
chemotactic cytokines and are used to differentiate between members of the chemokine 
superfamily [60]. In addition, the location of the MT gene cluster in both humans and mice is 
mapped closely to that of other chemokines such as CCL17 and CX3CL1 (Fig. 14). These 
observations suggest MT may display chemotactic activity [13].  
Experiments done in vitro using the ECIS/taxis system show that Jurkat T cells and WBC 
264-9C cells (macrophage-like cell line) chemotax in the presence of an MT gradient. This 
chemotactic response was blocked by treatment with monoclonal anti-MT antibodies. 
Chemotaxis was also blocked when the cells were first incubated with cholera toxin or pertussis 
toxin, indicating MT may elicit a chemotactic response via G-protein coupled receptor signaling 
[13]. It is well established that many chemokine receptors belong to a family of 7-
transmembrane-spanning G-protein coupled receptors, providing further support for MT as a 
chemotactic factor [60].  
Data indicating MT exists selectively outside of cells and acts as a chemotactic factor 
lead us to hypothesize that SmtA plays a similar role in cell trafficking. Like MT, SmtA does not 
carry an N-terminal signal sequence and may be secreted by a non-classical pathway. 
SecretomeP is a sequence-based prediction module for non-classically secreted mammalian and 
bacterial proteins [61]. After entering a protein sequence and indicating whether it is a 
mammalian sequence, gram-negative, or gram-positive bacterial sequence, the module gives the 
protein a SecP score. A SecP score above 0.5 indicates possible non-classical secretion. Analysis 
of the P. aeruginosa SmtA protein sequence by SecretomeP indicates it is likely to be non-
classically secreted (Table 2). In addition to SmtA, we analyzed the protein sequences of the 
mammalian metallothionein, MT-1F, as well as Mycobacterium tuberculosis glutamine 
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synthetase (GlnA) and Bacillus subtilis superoxide dismutase (SodA), both of which are known 
to exist extracellularly and thought to exit the cell by a non-classical secretion pathway. P. 
aeruginosa RNA polymerase (RNAP) was included in the analysis as a negative control. If 
found extracellularly during infection and shown capable of inducing immune cell chemotaxis, 
SmtA may constitute a large and intricate role in bacterial pathogenesis.  
SmtA as a chemotactic factor also has implications in the “danger signal” hypothesis. 
Studies suggest that stress response proteins such as MT can act as “danger signals”, alerting the 
immune response to action. The hypothesis proposes that sometimes non-self motifs will not 
elicit an effective response unless in the presence of tissue damage or other types of stress [62]. 
MT signals and responds to various types of stress (i.e. metal toxicity, oxidative stress, infection, 
etc.) and has been suggested to act as a danger signal [63]. From an evolution standpoint, MT 
may act as a danger signal because of its similarities to SmtA, which we have hypothesized may 
be secreted upon infection. The immune system may recognize similarities in mammalian MT to 
bacterial metallothioneins, falsely identifying metallothioneins as additional motifs of infection.   
 
SmtA in Pseudomonas infection 
We have shown that E. coli transformed with the  P. aeruginosa smtA gene is resistant to some 
forms of oxidative attack. Further exploration is necessary to determine whether SmtA provides 
protection against mammalian immune defense mechanisms in vivo. These initial results, 
however, have provided promising incentive to continue these studies and move into a model 
system more similar to the natural infection.  
E. coli do not naturally express SmtA, but the data suggests that the presence of SmtA is 
beneficial to the bacterium when challenged with ROS. Because the transfected smtA gene was 
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isolated from P. aeruginosa, the data also suggests that SmtA will have a protective effect 
against ROS attack in P. aeruginosa infection. P. aeruginosa are subject to a variety of oxidative 
assaults. As an airway pathogen, P. aeruginosa is exposed to high concentrations of atmospheric 
oxygen and must survive the respiratory bursts of alveolar macrophages. We have shown that 
SmtA protects MC1061 E. coli from the respiratory burst of RAW 267.4 macrophages. 
Similarly, we hypothesize that in an infection of alveolar macrophages, P. aeruginosa expressing 
SmtA will be better equipped for survival than P. aeruginosa deficient in SmtA.  
Pseudomonas is also a biofilm-forming organism, and it is clear that biofilm formation is 
responsible for many of the antibiotic-resistant characteristics of P. aeruginosa infections. 
Barraud et. al. (2006) demonstrated that one form of ROS in particular, NO, induces biofilm 
dispersal in P. aeruginosa [46]. Although we did not test SmtA’s ability to bind and neutralize 
NO specifically, we expect that SmtA is also capable of neutralizing this species of RNS. In 
addition, other types of oxidant species, such as H2O2, which we have shown to be neutralized by 
SmtA, may be capable of damaging or inhibiting the formation of pathogenic P. aeruginosa 
biofilms as well. If either were true, SmtA would further aid in the survival and persistence of P. 
aeruginosa by promoting biofilm formation. 
 
Proposed Pseudomonas aeruginosa system 
In our E. coli  model, we utilized two constructs of the pGEX-6P-1 plasmid, one containing the 
smtA gene and a second identical to the first but without the smtA gene insert. We have already 
shown that P. aeruginosa SmtA provides protection to E. coli when challenged with H2O2. 
Moving to P. aeruginosa as a model organism, we would like to take advantage of the bacteria’s 
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naturally present SmtA and compare its function at biological levels to P. aeruginosa 
experimentally lacking SmtA. 
To assess the role of SmtA, future experiments should compare wildtype P. aeruginosa 
with P. aeruginosa treated with small interfering RNA (siRNA) to prevent the translation of the 
SmtA protein. The RNAi pathway occurs naturally in many eukaryotic cells and functions to 
regulate gene expression post-transcriptionally. Small interfering RNAs (siRNA) are short 
double-stranded RNA molecules with two nucleotide-long 3’ overhangs. In the RNAi pathway, a 
single stranded siRNA assembles with Slicer, a RNase-like protein, to form an RNA-induced 
silencing complex (RISC). RISC then binds to mRNA sequences complementary to the bound 
siRNA sequence. Once bound, Slicer cleaves the target mRNA, which is now recognized by the 
cell as aberrant and is destroyed. Ideally, treatment with gene-specific siRNAs prevents 
translation of the target protein without many of the off-target effects experienced with gene 
knockouts.  
If SmtA provides protection to P. aeruginosa during mammalian infection, targeting 
SmtA with siRNA may be applicable to treatment of Pseudomonas infections. The idea of RNA 
interference (RNAi) as a treatment for disease would not be novel to our studies; however, it is 
an innovative approach and constitutes a popular area of research that holds valuable therapeutic 
promise. Recently, RNA interference was  highlighted as a treatment for HIV in humanized mice 
by blocking expression of CCR5 [64]. This research, along with other similar studies, provides 
the rationale for the use of RNA interference in our own research.  
Pseudomonas infections treated with siRNA may stop the production of SmtA and render 
the organism less able to cause disease than Pseudomonas actively producing SmtA. 
Pseudomonas infections often occur due to a temporary decrease in immune efficacy or 
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temporary damage to airway barriers. Typical treatment includes two antibiotics in combination: 
an anti-pseudomonal beta-lactam and an aminoglycoside. Beta-lactam antibiotics inhibit cell 
wall synthesis [65], while aminoglycoside antibiotics inhibit general bacterial protein synthesis 
[66]. Pseudomonas infections, however, have a tendency towards drug resistance, demonstrating 
a need for alternative therapies [67]. Developing a drug that would keep an infection under 
control until immune function is restored or until the airway repairs itself would allow the body, 
once healthy, to fight off the infection as it would normally in a healthy individual without the 
use of antibiotics. This would prevent multiple drug resistance infections and other undesirable 
side effects of antibiotic use. If SmtA proves to be a significant factor in bacterial defense against 
host immune mechanisms, therapeutic manipulation of SmtA may be a possible avenue of co-
treatment for patients with P. aeruginosa infection. In addition, the experimental procedure, if 
successful, would indicate the ability to halt the production of SmtA with siRNA, providing a 
specific method of therapeutic intervention that could be explored further. Ultimately, our 
research may elucidate a new opportunity to fight Pseudomonas infection. 
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Table 1.  
 SmtA Mammalian MT 
Molecular weight (kDa) 8 7 
# amino acids 56-79 60-61 
# cysteines (histidines) 8-9 (3) 18-23 
# bound zinc 3-4 7-8 
Specificity to UC1MT + + 
Specificity to UC2 - + 
TABLE 1. Comparison of Pseudomonas aeruginosa SmtA and eukaryotic MT. It has been 
previously determined that SmtA binds less zinc molecules than MT and uses both cysteine and 
histidine residues to capture heavy metals. An immunodot blot was used to test the antigenicity 
of GST-SmtA extracts to a mammalian MT specific antibody, UC1MT, and UC2, an antibody 
known to bind MT but has not been tested for specificity to other metalloproteins. MT-I was 
used as a control in these experiments. The (+) indicates binding while the (-) indicates a failure 
to bind.  
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Figure 1. 
 
FIGURE 1. ROS and mammalian antioxidants. In mammalian cells, ROS are produced 
during normal physiological processes (e.g. cellular respiration) and during disease states (e.g. 
inflammation). Under normal conditions, ROS are scavenged by superoxide dismutase (SOD), 
catalase, and glutathione (GSH) peroxidase. Oxidative stress occurs when there is an increase in 
oxidant species, a decrease in anti-oxidant activity, or when oxidative damage is not repaired. 
(Graphic provided by Sigma-Aldrich)
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Figure 2. 
 
 
 
 
 
 
 
FIGURE 2. Respiratory burst enzymatics. (A) NADPH oxidase catalyzes the formation of 
superoxide anions (O2-). Superoxide anions can then react with hydrogen ions spontaneously or 
catalyzed by superoxide dismutase (SOD) to form hydrogen peroxide (H2O2). (B) In the Haber-
Weiss reaction, superoxide anions react with hydrogen peroxide to form the potent hydroxyl 
radical (OH.). (C) Myeloperoxidase (MPO) catalyzes the formation of hypochlorous acid 
(HOCl), which partially dissociates to form hypochlorite (OCl-). 
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Figure 3.  
 
FIGURE 3. Comparison of cysteines in mammalian and bacterial metallothioneins. This 
alignment of human and mouse MT-I and Pseudomonas aeruginosa and Synechococcus SmtA 
shows 4 cysteines conserved in all 4 sequences (indicated by red carets).  
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Figure 4. 
 
 
FIGURE 4. SmtB action on the SmtA promoter. Apo SmtB contacts the SmtA operator-
promoter region at four sites: S1, S2, S3, and S4. The nucleotide sequence is shown below with 
nucleotide contact sites (sequence TGAA) in bold. (Adapted from Robinson et. al. 2001) 
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Figure 5. 
 
FIGURE 5. Active SmtB binds at four sites to form a tetrameric complex at smtA 
promoter. (A) SmtB (blue) is inactive when bound to Zn and will not contact the smtA 
promoter. (B) At low concentrations of Zn, active SmtB (apo) binds as a monomer or dimer 
(shown), which allows a low level of transcription. (C) When Zn is absent, SmtB forms a 
tetrameric complex, causing the DNA to bend, resulting in full inhibition of smtA transcription. 
(Adapted from Robinson et. al. 2001)
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Figure 6.  
 
 
FIGURE 6. pGEX-SMTA expression vector. The SmtA gene was cloned into the pGEX-6p-1 
expression vector between the between the EcoRI and XhoI sites. (Provided by D. Laukens, 
Ghent University) 
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Figure 7.  
 
FIGURE 7. Confirmation of pGEX-6P-1 transformation by gel electrophoresis. Bacterial 
DNA was isolated from a 24-hour culture of MC1061 +pGEX-6P-1, MC1061 +pGEX-SMTA, 
or MC1061 according to Maniatis et. al. 1982. The minipreparation was analyzed by gel 
electrophoresis on a 1% agarose gel containing 0.5ug/ml ethidium bromide. (SRD080210, 
SRD081310)
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Figure 8. 
 
 
 
 
 
FIGURE 8. Survival of E.coli MC1061+pGEX-SmtA and MC1061+pGEX-6P-1 after 
exposure to exogenous oxidants. E.coli MC1061 strains expressing either plasmid construct 
were sub-cultured from overnight cultures in a rich media containing IPTG to early log phase 
and monitored at OD600. The cultures were then aliquoted into 96-well plates and exposed to the 
various concentrations of H2O2 (upper panel), tBOOH (middle panel), or NaOCl (lower panel) at 
time zero. Values are compared to an untreated control culture maintained for the same duration. 
(SRD071509, SRD082409, SRD100709)
Time post treatment (min) 
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Figure 9.  
 
 
 
      
FIGURE 9. Survival of E.coli MC1061+pGEX-SmtA and MC1061+pGEX-6P-1 after 
exposure to H2O2. E.coli MC1061 strains expressing either plasmid construct were sub-cultured 
from overnight cultures in a rich media containing IPTG to early log phase and monitored at 
OD600. (A) The cultures were then exposed to a final concentration of 10mM H2O2 at time zero, 
aliquoted into a 96-well plate, and monitored at OD600. Values are compared to an untreated 
control culture maintained for the same duration. (B) A sample was taken at 60 minutes 
(indicated by arrow) and plated to determine CFU/ml (p<0.01). (C) Plates shown. E. coli + 
pGEX-SmtA treated with 10mM H2O2was diluted 10-1 (i) and E. coli + pGEX-6p-1 treated with 
10mM H2O2 was diluted 10-1 (ii). 20ul of each diluted culture was plated. (SRD120810)
    A 
    B   C 
Davis 
 40 
Figure 10.  
 
 
      
FIGURE 10. E. coli MC1061+pGEX-SmtA and MC1061+pGEX-6P-1 infection of 
RAW267.4 macrophages. The E. coli MC1061 strains expressing either plasmid construct were 
grown overnight and subcultured to log phase with IPTG present.  The RAW264.7 cells were 
grown to confluency and plated in 6 well plates.  The RAW264.7 cells were then infected with 
E.coli at an MOI of 5:1 and incubated in special gas at 37oC. The supernatant was removed after 
30 hours (upper panel) and 24 hours (lower panel) and plated to determine CFU/ml. (KMP)
         PGEX-SMTA         PGEX-6P-1 
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Figure 11. 
 
 
FIGURE 11. SmtA in long-term E. coli culture. MC1061 E. coli cultures (Parent MC1061 E. 
coli, MC1061 + pGEX-SmtA, and +pGEX-6p-1) were subcultured from overnight cultures in 
rich media and allowed to grow at 37o under constant shaking. At the time points indicated, a 
sample of each culture was plated on YTA plates to determine CFU/ml. (SRD062810) 
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Figure 12. 
 
FIGURE 12. GSH decreases chemiluminescence of luminol in the presence of H2O2. 
Solutions of GSH and catalase were prepared in HBSS. H2O2 was added to a final concentration 
of 1mM. Samples were incubated at RT for 30 minutes. A working solution of luminol-HRP was 
added to each sample and then immediately aliquoted into 96-well white plate and read at 
420nm. The value of the blank (HBSS and luminol-HRP working solution) was subtracted from 
each well. (SRD020611)
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Figure 13. 
 
FIGURE 13. GSH and N-acetyl-L-cysteine show similar linearity of reactive thiols. 
Working solution of CPM and sample solutions were added in a 1:1 dilution in triplicate to a 
black 96-well plate and incubated in the dark at RT for 1 hour. The plate was then read using an 
excitation wavelength of 387nm and an emission wavelength of 465nm. The value of the blank 
(100ul PBS and 100ul of CPM working solution) was subtracted from each well. (SRD032311)
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Figure 14. 
 
FIGURE 14. Metallothionein gene shows proximity to chemokine genes in mice and 
humans. Mouse chromosome eight is shown with the murine MT genes and homologous human 
MT genes highlighted in yellow. Chemokine genes highlighted in red. (Adapted from Yin et. al. 
2005) 
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Table 2. 
Organism Protein SecretomeP score 
Pseudomonas aeruginosa SmtA 0.652 
Homo sapiens MT-1F 0.865 
Bacillus subtilis GlnA 0.539 
Escherichia coli SodA 0.701 
Pseudomonas aeruginosa RNAP 0.219 
TABLE 2. Prediction of non-classical protein secretion by SecretomeP. SecretomeP is a 
sequence-based prediction module for mammalian and bacterial non-classical secretion. Protein 
sequences were inputted into the module to obtain a SecretomeP score. A score above 0.5 
indicates possible non-classical secretion.  
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